Federal regulators have signed off on a new type of flu vaccine with a booster in it, with the hope of better protecting seniors from the virus.
It’s the first flu vaccine to include what’s called an adjuvant — a compound that helps stimulate the immune system so that a vaccine is more effective.
It’s aimed at people over 65, who typically have a poor immune response to vaccines.
“Immunizing individuals in this age group is especially important because they bear the greatest burden of severe influenza disease and account…
- Climate-Conscious Architects Want Europe To Build Less
- The Red-State Governor Who's Not Afraid to Be 'Woke'
- Jonathan Van Ness: We Are Still Not Taking Monkeypox Seriously Enough
- The Not-So-Romantic Return of Europe's Sleeper Trains
- This Filmmaker Set Out To Record Her Family’s Journey Rebuilding Afghanistan. Her Work Is a Reminder of What’s at Stake
- Why Sunscreen Ingredients Need More Safety Data
- What Historians Think of the Joe Biden-Jimmy Carter Comparisons
- Author Mimi Zhu Is Relearning What It Means to Love After Trauma